1.02
price up icon25.91%   0.2099
after-market 시간 외 거래: 1.09 0.07 +6.86%
loading
전일 마감가:
$0.8101
열려 있는:
$0.84
하루 거래량:
1.81M
Relative Volume:
1.78
시가총액:
$164.99M
수익:
-
순이익/손실:
$-274.18M
주가수익비율:
-0.4024
EPS:
-2.5346
순현금흐름:
$-198.33M
1주 성능:
+42.40%
1개월 성능:
+51.61%
6개월 성능:
-90.09%
1년 성능:
-89.73%
1일 변동 폭
Value
$0.8125
$1.05
1주일 범위
Value
$0.69
$1.05
52주 변동 폭
Value
$0.611
$17.19

Neumora Therapeutics Inc Stock (NMRA) Company Profile

Name
명칭
Neumora Therapeutics Inc
Name
전화
(857) 760-0900
Name
주소
490 ARSENAL WAY, SUITE 200, WATERTOWN
Name
직원
103
Name
트위터
Name
다음 수익 날짜
2025-03-03
Name
최신 SEC 제출 서류
Name
NMRA's Discussions on Twitter

NMRA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
NMRA
Neumora Therapeutics Inc
1.02 116.25M 0 -274.18M -198.33M -2.5346
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.232 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.34 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 65.36B 14.09B 4.50B 2.96B 39.28

Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-02 다운그레이드 BofA Securities Buy → Underperform
2025-03-10 다운그레이드 William Blair Outperform → Mkt Perform
2025-03-07 다운그레이드 Guggenheim Buy → Neutral
2025-03-07 다운그레이드 Stifel Buy → Hold
2025-01-02 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-11-05 다운그레이드 JP Morgan Overweight → Neutral
2024-10-01 개시 H.C. Wainwright Buy
2024-07-22 개시 Needham Buy
2024-07-08 개시 Mizuho Outperform
2023-12-12 개시 Deutsche Bank Hold
2023-10-10 개시 BofA Securities Buy
2023-10-10 개시 Guggenheim Buy
2023-10-10 개시 JP Morgan Overweight
2023-10-10 개시 RBC Capital Mkts Outperform
2023-10-10 개시 Stifel Buy
2023-10-10 개시 William Blair Outperform
모두보기

Neumora Therapeutics Inc 주식(NMRA)의 최신 뉴스

pulisher
Jun 01, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Recommendation of “Hold” by Analysts - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Jun 01, 2025
pulisher
Jun 01, 2025

Ameriprise Financial Inc. Takes Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Neumora Therapeutics Holds Annual Stockholders Meeting - TipRanks

May 30, 2025
pulisher
May 29, 2025

BNP Paribas Financial Markets Invests $221,000 in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

May 29, 2025
pulisher
May 28, 2025

Deutsche Bank AG Has $775,000 Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

May 28, 2025
pulisher
May 27, 2025

Kuehn Law Encourages Investors of Grocery Outlet Holding Corp. to Contact Law Firm - GlobeNewswire Inc.

May 27, 2025
pulisher
May 25, 2025

26,500 Shares in Neumora Therapeutics, Inc. (NASDAQ:NMRA) Bought by Janus Henderson Group PLC - Defense World

May 25, 2025
pulisher
May 22, 2025

Neumora Therapeutics’s SWOT analysis: navigating challenges in neuropsychiatric drug development - Investing.com India

May 22, 2025
pulisher
May 22, 2025

Undervalued Opportunities: 3 Penny Stocks With Market Caps Above $30M - simplywall.st

May 22, 2025
pulisher
May 21, 2025

Softbank Group CORP. Sells 1,005,726 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

May 21, 2025
pulisher
May 20, 2025

Price T Rowe Associates Inc. MD Cuts Stock Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

May 20, 2025
pulisher
May 19, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Purchased by Northern Trust Corp - Defense World

May 19, 2025
pulisher
May 18, 2025

Orbimed Advisors LLC Has $8.53 Million Stock Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

May 18, 2025
pulisher
May 18, 2025

Neumora Therapeutics (NASDAQ:NMRA) Earns "Buy" Rating from Needham & Company LLC - MarketBeat

May 18, 2025
pulisher
May 17, 2025

HC Wainwright Has Pessimistic Outlook of NMRA Q2 Earnings - MarketBeat

May 17, 2025
pulisher
May 17, 2025

Neumora Therapeutics faces Nasdaq delisting risk - Investing.com Australia

May 17, 2025
pulisher
May 17, 2025

The Manufacturers Life Insurance Company Has $478,000 Holdings in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

May 17, 2025
pulisher
May 17, 2025

Neumora Therapeutics (NASDAQ:NMRA) Releases Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat

May 17, 2025
pulisher
May 16, 2025

Neumora Therapeutics faces Nasdaq delisting risk By Investing.com - Investing.com India

May 16, 2025
pulisher
May 16, 2025

Neumora Therapeutics Faces Nasdaq Non-Compliance Notice - TipRanks

May 16, 2025
pulisher
May 16, 2025

Neumora Therapeutics Inc On May 14, Receives Nasdaq Non-Compliance Notice - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

What is HC Wainwright’s Forecast for NMRA Q2 Earnings? - Defense World

May 16, 2025
pulisher
May 16, 2025

William Blair Analysts Increase Earnings Estimates for NMRA - Defense World

May 16, 2025
pulisher
May 15, 2025

Neumora Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 15, 2025
pulisher
May 14, 2025

Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm - The Malaysian Reserve

May 14, 2025
pulisher
May 13, 2025

Neumora Therapeutics, Inc.: Strengthened Financial Position and Strategic Operational Enhancements Drive Buy Rating - TipRanks

May 13, 2025
pulisher
May 13, 2025

Neumora Therapeutics Venture Debt Facility - Leerink Partners

May 13, 2025
pulisher
May 13, 2025

Neumora Therapeutics (NMRA) Retains Buy Rating with Stable Price Target | NMRA Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Strategic Developments and Long-Term Growth Prospects for Neumora Therapeutics Amid Financial Stability Enhancements - TipRanks

May 13, 2025
pulisher
May 13, 2025

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Neumora Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 13, 2025
pulisher
May 12, 2025

Earnings call transcript: Neumora Therapeutics Q1 2025 Sees Net Loss, Stock Rises - Investing.com

May 12, 2025
pulisher
May 12, 2025

Neumora Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Transcript : Neumora Therapeutics, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com

May 12, 2025
pulisher
May 11, 2025

Will Neumora Therapeutics (NASDAQ:NMRA) Spend Its Cash Wisely? - Yahoo Finance

May 11, 2025
pulisher
May 11, 2025

Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025NMRA - ACCESS Newswire

May 11, 2025
pulisher
May 10, 2025

Neumora Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025NMRA - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Neumora Therapeutics (NMRA) Expected to Announce Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Neumora Therapeutics Inc (NASDAQ: NMRA): What Matters Now - Stocksregister

May 09, 2025
pulisher
May 09, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Rating of "Hold" by Analysts - MarketBeat

May 09, 2025
pulisher
May 08, 2025

Schonfeld Strategic Advisors LLC Buys 381,676 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

May 08, 2025
pulisher
May 07, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Rating of “Hold” by Analysts - Defense World

May 07, 2025
pulisher
May 06, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

May 06, 2025
pulisher
May 05, 2025

Neumora Therapeutics (NMRA) Projected to Post Quarterly Earnings on Monday - MarketBeat

May 05, 2025
pulisher
May 04, 2025

Invesco Ltd. Raises Holdings in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

May 04, 2025
pulisher
May 02, 2025

NMRA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - NatLawReview.com

May 02, 2025
pulisher
May 02, 2025

Nothing is Better Than Neumora Therapeutics Inc (NMRA) stock at the moment - Sete News

May 02, 2025
pulisher
May 02, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Stock Position Increased by Wells Fargo & Company MN - Defense World

May 02, 2025

Neumora Therapeutics Inc (NMRA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Neumora Therapeutics Inc 주식 (NMRA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
BERNS PAUL L
See Remarks
Feb 18 '25
Sale
1.69
13,871
23,468
7,405,004
Milligan Michael Lee
See Remarks
Feb 18 '25
Sale
1.69
1,978
3,351
22,470
Aurora Daljit Singh
Chief Strategy Officer
Feb 18 '25
Sale
1.68
8,565
14,347
88,935
Lenz Robert A.
Head of R&D
Feb 18 '25
Sale
1.67
5,614
9,383
309,092
Pinto Joshua
President
Feb 18 '25
Sale
1.67
8,048
13,477
76,952
$1.15
price up icon 0.00%
$585.93
price up icon 0.92%
$300.83
price down icon 2.33%
$38.11
price up icon 4.30%
$4.73
price down icon 1.69%
$493.22
price up icon 2.10%
자본화:     |  볼륨(24시간):